Pillstats
Rx only · Capsule, Delayed Release · Oral

Pancrelipase Lipase, Pancrelipase Protease, Pancrelipase Amylase

Brands: Zenpep · Pancrelipase Amylase + Pancrelipase Lipase + Pancrelipase Protease

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US8 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)743
US makers1 labelers
Packages14
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.64$5.28$7.92$10.56Dec 2025Jun 2026Jul 2026
$9.182
Latest avg · Jul 22, 2026
-0%
Since Dec 31, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8.7K17K26K35K2025 Q12025 Q22025 Q32025 Q42026 Q1
27K
Rx · 2026 Q1
6.8M
Units dispensed
-11%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aimmune Therapeutics, Inc.unknown14SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.